A Cluster Crossover Randomized Controlled Trial of Manual T-piece Versus Ventilator Positive Pressure Ventilation During Resuscitation of Extremely Premature Neonates: The MVP Trial
A Cluster Crossover Randomized Controlled Trial of Manual T-piece Versus Ventilator Positive Pressure Ventilation During Resuscitation of Extremely Premature Neonates: The MVP Trial
Many extremely premature infants require immediate help with breathing after birth. Positive pressure ventilation (PPV) using a device called a T-piece resuscitator is a common method. PPV is needed to establish proper lung function, improve gas exchange, and encourage the infant to breathe spontaneously. However, T-piece resuscitators have limitations, like a lack of visual feedback and variable settings, which may result in reduced effectiveness of PPV. Improving PPV effectiveness may reduce the need for more invasive procedures, such as intubation, which pose an increased risk of complications and death for these fragile infants. A novel approach, that may overcome the above limitations and deliver PPV with precise settings through a nasal mask, is to use a ventilator to deliver PPV (V-PPV) using a respiratory mode called nasal intermittent positive pressure ventilation (NIPPV). While NIPPV is commonly used in neonatal intensive care units to support breathing in premature infants, the impact of V-PPV use during immediate post-birth stabilization needs to be studied. Preliminary data from our recent single-center study confirmed the feasibility of using V-PPV for resuscitation of extremely premature babies and indicated its potential superiority with a 28% decrease in the need for intubation compared to historical use of T-piece. This promising innovation may enhance outcomes for these vulnerable infants by refining the way we provide respiratory support in their critical first moments. The research objective is to compare the clinical outcomes of extremely premature infants receiving manual T-piece versus V-PPV during immediate post-birth stabilization. The primary aim is to evaluate the impact of V-PPV on major health complications or death. This study seeks to provide insights into improving the care and outcomes of these infants during a critical stage of transition from fetus to newborn.
Inclusion Criteria::
Exclusion Criteria:
thaiani.wulff@sinaihealth.ca1-416-586-4800. ext. 176746
laura.thomas@sinaihealth.ca416-586-4800 ext. 172060
Los Angeles, California 90505, United States
biniwale@usc.edu310-423-4434
Montral, Quebec, Canada
marc.beltempo@mcgill.ca514-412-4230 ext. 23032
amuchou.soraisham@albertahealthservices.ca403-944-4638
georg.schmoelzer@me.com780-735-4647
jonathan.wong@cw.bc.ca604-875-200 ext. 7344
mukerji@mcmaster.ca905-521-2100 ext. 76486
kevin.coughlin@lhsc.on.ca519-685-8500 ext. 64818
michelle.baczynski@sinaihealth.ca4165864800 ext. 173037
ahmed.moussa.med@ssss.gouv.qc.ca514-345-4931 ext. 3109
christian.heiring@regionh.dk